8329 — Shenzhen Neptunus Interlong Bio-technique Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$206.39m
- HK$115.54m
- CNY972.01m
Annual cashflow statement for Shenzhen Neptunus Interlong Bio-technique Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 39.1 | 82.3 | 30.7 | 29.6 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 4.11 | 6.09 | 28.2 | 11.8 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -143 | -63.1 | -38.9 | -51.6 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -69.9 | 61.2 | 53.7 | 24.4 | — |
| Capital Expenditures | -15.1 | -19.7 | -15.4 | -22.2 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -166 | 30.5 | 76.3 | -92.4 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -182 | 10.8 | 60.9 | -115 | — |
| Financing Cash Flow Items | 20.5 | 10.9 | -29.2 | -8.69 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 66.7 | -9.02 | -32.5 | 1.43 | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -185 | 63 | 82.1 | -88.8 | — |